drugset / Trial / NCT04446312
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
Timeline
- Start
- 2020-07-13
- Primary completion
- 2021-01-07
- Completion
- 2021-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BLI4900 | Unknown | 2000 ml | Oral |
Indications
No indication recorded.